臓器移植拒絶反応薬物のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Organ Transplant Rejection Medicine Market Insights and Forecast to 2028

• レポートコード：QY2203B11786
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界の臓器移植拒絶反応薬物の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に臓器移植拒絶反応薬物の世界市場のxxx％を占める「ステロイド」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「腎臓移植」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国の臓器移植拒絶反応薬物の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの臓器移植拒絶反応薬物市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの臓器移植拒絶反応薬物市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

臓器移植拒絶反応薬物のグローバル主要メーカーには、GlaxoSmithKline plc、Novartis AG、F. Hoffmann-La Roche Ltd.、Astellas Pharma, Inc.、Pfizer, Inc.、AbbVie, Inc.、Allergan plc.、Bristol-Myers Squibb Company、Sanofiなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

臓器移植拒絶反応薬物市場は、種類と用途によって区分されます。世界の臓器移植拒絶反応薬物市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
ステロイド、抗体、mTOR阻害剤、抗増殖剤、カルシニューリン阻害剤

【用途別セグメント】
腎臓移植、骨骨髄移植、肝移植、心臓移植、肺移植、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 臓器移植拒絶反応薬物製品概要
- 種類別市場（ステロイド、抗体、mTOR阻害剤、抗増殖剤、カルシニューリン阻害剤）
- 用途別市場（腎臓移植、骨骨髄移植、肝移植、心臓移植、肺移植、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界の臓器移植拒絶反応薬物販売量予測2017-2028
- 世界の臓器移植拒絶反応薬物売上予測2017-2028
- 臓器移植拒絶反応薬物の地域別販売量
- 臓器移植拒絶反応薬物の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別臓器移植拒絶反応薬物販売量
- 主要メーカー別臓器移植拒絶反応薬物売上
- 主要メーカー別臓器移植拒絶反応薬物価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（ステロイド、抗体、mTOR阻害剤、抗増殖剤、カルシニューリン阻害剤）
- 臓器移植拒絶反応薬物の種類別販売量
- 臓器移植拒絶反応薬物の種類別売上
- 臓器移植拒絶反応薬物の種類別価格
・用途別市場規模（腎臓移植、骨骨髄移植、肝移植、心臓移植、肺移植、その他）
- 臓器移植拒絶反応薬物の用途別販売量
- 臓器移植拒絶反応薬物の用途別売上
- 臓器移植拒絶反応薬物の用途別価格
・北米市場
- 北米の臓器移植拒絶反応薬物市場規模（種類別、用途別）
- 主要国別の臓器移植拒絶反応薬物市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの臓器移植拒絶反応薬物市場規模（種類別、用途別）
- 主要国別の臓器移植拒絶反応薬物市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の臓器移植拒絶反応薬物市場規模（種類別、用途別）
- 主要国別の臓器移植拒絶反応薬物市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の臓器移植拒絶反応薬物市場規模（種類別、用途別）
- 主要国別の臓器移植拒絶反応薬物市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの臓器移植拒絶反応薬物市場規模（種類別、用途別）
- 主要国別の臓器移植拒絶反応薬物市場規模（トルコ、サウジアラビア）
・企業情報
GlaxoSmithKline plc、Novartis AG、F. Hoffmann-La Roche Ltd.、Astellas Pharma, Inc.、Pfizer, Inc.、AbbVie, Inc.、Allergan plc.、Bristol-Myers Squibb Company、Sanofi
・産業チェーン及び販売チャネル分析
- 臓器移植拒絶反応薬物の産業チェーン分析
- 臓器移植拒絶反応薬物の原材料
- 臓器移植拒絶反応薬物の生産プロセス
- 臓器移植拒絶反応薬物の販売及びマーケティング
- 臓器移植拒絶反応薬物の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 臓器移植拒絶反応薬物の産業動向
- 臓器移植拒絶反応薬物のマーケットドライバー
- 臓器移植拒絶反応薬物の課題
- 臓器移植拒絶反応薬物の阻害要因
・主な調査結果

Organ Transplant Rejection Medicine have enhanced short-term graft survival and minimized the rate of acute organ transplant rejection.
Market Analysis and Insights: Global Organ Transplant Rejection Medicine Market
Due to the COVID-19 pandemic, the global Organ Transplant Rejection Medicine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Steroids accounting for % of the Organ Transplant Rejection Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Kidney Transplant segment is altered to an % CAGR throughout this forecast period.
China Organ Transplant Rejection Medicine market size is valued at US$ million in 2021, while the US and Europe Organ Transplant Rejection Medicine are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Organ Transplant Rejection Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Organ Transplant Rejection Medicine include GlaxoSmithKline plc, Novartis AG, F. Hoffmann-La Roche Ltd., Astellas Pharma, Inc., Pfizer, Inc., AbbVie, Inc., Allergan plc., Bristol-Myers Squibb Company and Sanofi. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Organ Transplant Rejection Medicine Scope and Segment
Organ Transplant Rejection Medicine market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Organ Transplant Rejection Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Steroids
Antibodies
mTOR Inhibitors
Antiproliferative Agents
Calcineurin Inhibitors
Segment by Application
Kidney Transplant
Bone Marrow Transplant
Liver Transplant
Heart Transplant
Lung Transplant
Others
By Company
GlaxoSmithKline plc
Novartis AG
F. Hoffmann-La Roche Ltd.
Astellas Pharma, Inc.
Pfizer, Inc.
AbbVie, Inc.
Allergan plc.
Bristol-Myers Squibb Company
Sanofi
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Organ Transplant Rejection Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Organ Transplant Rejection Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Steroids
1.2.3 Antibodies
1.2.4 mTOR Inhibitors
1.2.5 Antiproliferative Agents
1.2.6 Calcineurin Inhibitors
1.3 Market by Application
1.3.1 Global Organ Transplant Rejection Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Kidney Transplant
1.3.3 Bone Marrow Transplant
1.3.4 Liver Transplant
1.3.5 Heart Transplant
1.3.6 Lung Transplant
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Organ Transplant Rejection Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Organ Transplant Rejection Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Organ Transplant Rejection Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Organ Transplant Rejection Medicine Sales by Region
2.4.1 Global Organ Transplant Rejection Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Organ Transplant Rejection Medicine by Region (2023-2028)
2.5 Global Organ Transplant Rejection Medicine Revenue by Region
2.5.1 Global Organ Transplant Rejection Medicine Revenue by Region (2017-2022)
2.5.2 Global Organ Transplant Rejection Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Organ Transplant Rejection Medicine Sales by Manufacturers
3.1.1 Global Top Organ Transplant Rejection Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Organ Transplant Rejection Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Organ Transplant Rejection Medicine in 2021
3.2 Global Organ Transplant Rejection Medicine Revenue by Manufacturers
3.2.1 Global Organ Transplant Rejection Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Organ Transplant Rejection Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Organ Transplant Rejection Medicine Revenue in 2021
3.3 Global Organ Transplant Rejection Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Organ Transplant Rejection Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Organ Transplant Rejection Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Organ Transplant Rejection Medicine Sales by Type
4.1.1 Global Organ Transplant Rejection Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Organ Transplant Rejection Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Organ Transplant Rejection Medicine Sales Market Share by Type (2017-2028)
4.2 Global Organ Transplant Rejection Medicine Revenue by Type
4.2.1 Global Organ Transplant Rejection Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Organ Transplant Rejection Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Organ Transplant Rejection Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Organ Transplant Rejection Medicine Price by Type
4.3.1 Global Organ Transplant Rejection Medicine Price by Type (2017-2022)
4.3.2 Global Organ Transplant Rejection Medicine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Organ Transplant Rejection Medicine Sales by Application
5.1.1 Global Organ Transplant Rejection Medicine Historical Sales by Application (2017-2022)
5.1.2 Global Organ Transplant Rejection Medicine Forecasted Sales by Application (2023-2028)
5.1.3 Global Organ Transplant Rejection Medicine Sales Market Share by Application (2017-2028)
5.2 Global Organ Transplant Rejection Medicine Revenue by Application
5.2.1 Global Organ Transplant Rejection Medicine Historical Revenue by Application (2017-2022)
5.2.2 Global Organ Transplant Rejection Medicine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Organ Transplant Rejection Medicine Revenue Market Share by Application (2017-2028)
5.3 Global Organ Transplant Rejection Medicine Price by Application
5.3.1 Global Organ Transplant Rejection Medicine Price by Application (2017-2022)
5.3.2 Global Organ Transplant Rejection Medicine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Organ Transplant Rejection Medicine Market Size by Type
6.1.1 North America Organ Transplant Rejection Medicine Sales by Type (2017-2028)
6.1.2 North America Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
6.2 North America Organ Transplant Rejection Medicine Market Size by Application
6.2.1 North America Organ Transplant Rejection Medicine Sales by Application (2017-2028)
6.2.2 North America Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
6.3 North America Organ Transplant Rejection Medicine Market Size by Country
6.3.1 North America Organ Transplant Rejection Medicine Sales by Country (2017-2028)
6.3.2 North America Organ Transplant Rejection Medicine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Organ Transplant Rejection Medicine Market Size by Type
7.1.1 Europe Organ Transplant Rejection Medicine Sales by Type (2017-2028)
7.1.2 Europe Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
7.2 Europe Organ Transplant Rejection Medicine Market Size by Application
7.2.1 Europe Organ Transplant Rejection Medicine Sales by Application (2017-2028)
7.2.2 Europe Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
7.3 Europe Organ Transplant Rejection Medicine Market Size by Country
7.3.1 Europe Organ Transplant Rejection Medicine Sales by Country (2017-2028)
7.3.2 Europe Organ Transplant Rejection Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Organ Transplant Rejection Medicine Market Size by Type
8.1.1 Asia Pacific Organ Transplant Rejection Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Organ Transplant Rejection Medicine Market Size by Application
8.2.1 Asia Pacific Organ Transplant Rejection Medicine Sales by Application (2017-2028)
8.2.2 Asia Pacific Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
8.3 Asia Pacific Organ Transplant Rejection Medicine Market Size by Region
8.3.1 Asia Pacific Organ Transplant Rejection Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Organ Transplant Rejection Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Organ Transplant Rejection Medicine Market Size by Type
9.1.1 Latin America Organ Transplant Rejection Medicine Sales by Type (2017-2028)
9.1.2 Latin America Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
9.2 Latin America Organ Transplant Rejection Medicine Market Size by Application
9.2.1 Latin America Organ Transplant Rejection Medicine Sales by Application (2017-2028)
9.2.2 Latin America Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
9.3 Latin America Organ Transplant Rejection Medicine Market Size by Country
9.3.1 Latin America Organ Transplant Rejection Medicine Sales by Country (2017-2028)
9.3.2 Latin America Organ Transplant Rejection Medicine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Organ Transplant Rejection Medicine Market Size by Type
10.1.1 Middle East and Africa Organ Transplant Rejection Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Organ Transplant Rejection Medicine Market Size by Application
10.2.1 Middle East and Africa Organ Transplant Rejection Medicine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
10.3 Middle East and Africa Organ Transplant Rejection Medicine Market Size by Country
10.3.1 Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Organ Transplant Rejection Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Corporation Information
11.1.2 GlaxoSmithKline plc Overview
11.1.3 GlaxoSmithKline plc Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline plc Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline plc Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis AG Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis AG Recent Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd. Overview
11.3.3 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.4 Astellas Pharma, Inc.
11.4.1 Astellas Pharma, Inc. Corporation Information
11.4.2 Astellas Pharma, Inc. Overview
11.4.3 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Astellas Pharma, Inc. Recent Developments
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Corporation Information
11.5.2 Pfizer, Inc. Overview
11.5.3 Pfizer, Inc. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer, Inc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer, Inc. Recent Developments
11.6 AbbVie, Inc.
11.6.1 AbbVie, Inc. Corporation Information
11.6.2 AbbVie, Inc. Overview
11.6.3 AbbVie, Inc. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AbbVie, Inc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AbbVie, Inc. Recent Developments
11.7 Allergan plc.
11.7.1 Allergan plc. Corporation Information
11.7.2 Allergan plc. Overview
11.7.3 Allergan plc. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Allergan plc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Allergan plc. Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Corporation Information
11.8.2 Bristol-Myers Squibb Company Overview
11.8.3 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Company Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Overview
11.9.3 Sanofi Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Organ Transplant Rejection Medicine Industry Chain Analysis
12.2 Organ Transplant Rejection Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Organ Transplant Rejection Medicine Production Mode & Process
12.4 Organ Transplant Rejection Medicine Sales and Marketing
12.4.1 Organ Transplant Rejection Medicine Sales Channels
12.4.2 Organ Transplant Rejection Medicine Distributors
12.5 Organ Transplant Rejection Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Organ Transplant Rejection Medicine Industry Trends
13.2 Organ Transplant Rejection Medicine Market Drivers
13.3 Organ Transplant Rejection Medicine Market Challenges
13.4 Organ Transplant Rejection Medicine Market Restraints
14 Key Findings in The Global Organ Transplant Rejection Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Organ Transplant Rejection Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Steroids
Table 3. Major Manufacturers of Antibodies
Table 4. Major Manufacturers of mTOR Inhibitors
Table 5. Major Manufacturers of Antiproliferative Agents
Table 6. Major Manufacturers of Calcineurin Inhibitors
Table 7. Global Organ Transplant Rejection Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Organ Transplant Rejection Medicine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Organ Transplant Rejection Medicine Sales by Region (2017-2022) & (K Units)
Table 10. Global Organ Transplant Rejection Medicine Sales Market Share by Region (2017-2022)
Table 11. Global Organ Transplant Rejection Medicine Sales by Region (2023-2028) & (K Units)
Table 12. Global Organ Transplant Rejection Medicine Sales Market Share by Region (2023-2028)
Table 13. Global Organ Transplant Rejection Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Organ Transplant Rejection Medicine Revenue Market Share by Region (2017-2022)
Table 15. Global Organ Transplant Rejection Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Organ Transplant Rejection Medicine Revenue Market Share by Region (2023-2028)
Table 17. Global Organ Transplant Rejection Medicine Sales by Manufacturers (2017-2022) & (K Units)
Table 18. Global Organ Transplant Rejection Medicine Sales Share by Manufacturers (2017-2022)
Table 19. Global Organ Transplant Rejection Medicine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Organ Transplant Rejection Medicine Revenue Share by Manufacturers (2017-2022)
Table 21. Organ Transplant Rejection Medicine Price by Manufacturers (2017-2022) &(US$/Unit)
Table 22. Global Organ Transplant Rejection Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Organ Transplant Rejection Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplant Rejection Medicine as of 2021)
Table 24. Organ Transplant Rejection Medicine Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Organ Transplant Rejection Medicine Product Offered
Table 26. Date of Manufacturers Enter into Organ Transplant Rejection Medicine Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Organ Transplant Rejection Medicine Sales by Type (2017-2022) & (K Units)
Table 29. Global Organ Transplant Rejection Medicine Sales by Type (2023-2028) & (K Units)
Table 30. Global Organ Transplant Rejection Medicine Sales Share by Type (2017-2022)
Table 31. Global Organ Transplant Rejection Medicine Sales Share by Type (2023-2028)
Table 32. Global Organ Transplant Rejection Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Organ Transplant Rejection Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Organ Transplant Rejection Medicine Revenue Share by Type (2017-2022)
Table 35. Global Organ Transplant Rejection Medicine Revenue Share by Type (2023-2028)
Table 36. Organ Transplant Rejection Medicine Price by Type (2017-2022) & (US$/Unit)
Table 37. Global Organ Transplant Rejection Medicine Price Forecast by Type (2023-2028) & (US$/Unit)
Table 38. Global Organ Transplant Rejection Medicine Sales by Application (2017-2022) & (K Units)
Table 39. Global Organ Transplant Rejection Medicine Sales by Application (2023-2028) & (K Units)
Table 40. Global Organ Transplant Rejection Medicine Sales Share by Application (2017-2022)
Table 41. Global Organ Transplant Rejection Medicine Sales Share by Application (2023-2028)
Table 42. Global Organ Transplant Rejection Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Organ Transplant Rejection Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Organ Transplant Rejection Medicine Revenue Share by Application (2017-2022)
Table 45. Global Organ Transplant Rejection Medicine Revenue Share by Application (2023-2028)
Table 46. Organ Transplant Rejection Medicine Price by Application (2017-2022) & (US$/Unit)
Table 47. Global Organ Transplant Rejection Medicine Price Forecast by Application (2023-2028) & (US$/Unit)
Table 48. North America Organ Transplant Rejection Medicine Sales by Type (2017-2022) & (K Units)
Table 49. North America Organ Transplant Rejection Medicine Sales by Type (2023-2028) & (K Units)
Table 50. North America Organ Transplant Rejection Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Organ Transplant Rejection Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Organ Transplant Rejection Medicine Sales by Application (2017-2022) & (K Units)
Table 53. North America Organ Transplant Rejection Medicine Sales by Application (2023-2028) & (K Units)
Table 54. North America Organ Transplant Rejection Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Organ Transplant Rejection Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Organ Transplant Rejection Medicine Sales by Country (2017-2022) & (K Units)
Table 57. North America Organ Transplant Rejection Medicine Sales by Country (2023-2028) & (K Units)
Table 58. North America Organ Transplant Rejection Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Organ Transplant Rejection Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Organ Transplant Rejection Medicine Sales by Type (2017-2022) & (K Units)
Table 61. Europe Organ Transplant Rejection Medicine Sales by Type (2023-2028) & (K Units)
Table 62. Europe Organ Transplant Rejection Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Organ Transplant Rejection Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Organ Transplant Rejection Medicine Sales by Application (2017-2022) & (K Units)
Table 65. Europe Organ Transplant Rejection Medicine Sales by Application (2023-2028) & (K Units)
Table 66. Europe Organ Transplant Rejection Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Organ Transplant Rejection Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Organ Transplant Rejection Medicine Sales by Country (2017-2022) & (K Units)
Table 69. Europe Organ Transplant Rejection Medicine Sales by Country (2023-2028) & (K Units)
Table 70. Europe Organ Transplant Rejection Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Organ Transplant Rejection Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Organ Transplant Rejection Medicine Sales by Type (2017-2022) & (K Units)
Table 73. Asia Pacific Organ Transplant Rejection Medicine Sales by Type (2023-2028) & (K Units)
Table 74. Asia Pacific Organ Transplant Rejection Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Organ Transplant Rejection Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Organ Transplant Rejection Medicine Sales by Application (2017-2022) & (K Units)
Table 77. Asia Pacific Organ Transplant Rejection Medicine Sales by Application (2023-2028) & (K Units)
Table 78. Asia Pacific Organ Transplant Rejection Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Organ Transplant Rejection Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Organ Transplant Rejection Medicine Sales by Region (2017-2022) & (K Units)
Table 81. Asia Pacific Organ Transplant Rejection Medicine Sales by Region (2023-2028) & (K Units)
Table 82. Asia Pacific Organ Transplant Rejection Medicine Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Organ Transplant Rejection Medicine Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Organ Transplant Rejection Medicine Sales by Type (2017-2022) & (K Units)
Table 85. Latin America Organ Transplant Rejection Medicine Sales by Type (2023-2028) & (K Units)
Table 86. Latin America Organ Transplant Rejection Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Organ Transplant Rejection Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Organ Transplant Rejection Medicine Sales by Application (2017-2022) & (K Units)
Table 89. Latin America Organ Transplant Rejection Medicine Sales by Application (2023-2028) & (K Units)
Table 90. Latin America Organ Transplant Rejection Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Organ Transplant Rejection Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Organ Transplant Rejection Medicine Sales by Country (2017-2022) & (K Units)
Table 93. Latin America Organ Transplant Rejection Medicine Sales by Country (2023-2028) & (K Units)
Table 94. Latin America Organ Transplant Rejection Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Organ Transplant Rejection Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Organ Transplant Rejection Medicine Sales by Type (2017-2022) & (K Units)
Table 97. Middle East and Africa Organ Transplant Rejection Medicine Sales by Type (2023-2028) & (K Units)
Table 98. Middle East and Africa Organ Transplant Rejection Medicine Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Organ Transplant Rejection Medicine Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Organ Transplant Rejection Medicine Sales by Application (2017-2022) & (K Units)
Table 101. Middle East and Africa Organ Transplant Rejection Medicine Sales by Application (2023-2028) & (K Units)
Table 102. Middle East and Africa Organ Transplant Rejection Medicine Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Organ Transplant Rejection Medicine Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2017-2022) & (K Units)
Table 105. Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2023-2028) & (K Units)
Table 106. Middle East and Africa Organ Transplant Rejection Medicine Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Organ Transplant Rejection Medicine Revenue by Country (2023-2028) & (US$ Million)
Table 108. GlaxoSmithKline plc Corporation Information
Table 109. GlaxoSmithKline plc Description and Major Businesses
Table 110. GlaxoSmithKline plc Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 111. GlaxoSmithKline plc Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. GlaxoSmithKline plc Recent Developments
Table 113. Novartis AG Corporation Information
Table 114. Novartis AG Description and Major Businesses
Table 115. Novartis AG Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 116. Novartis AG Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Novartis AG Recent Developments
Table 118. F. Hoffmann-La Roche Ltd. Corporation Information
Table 119. F. Hoffmann-La Roche Ltd. Description and Major Businesses
Table 120. F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 121. F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. F. Hoffmann-La Roche Ltd. Recent Developments
Table 123. Astellas Pharma, Inc. Corporation Information
Table 124. Astellas Pharma, Inc. Description and Major Businesses
Table 125. Astellas Pharma, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 126. Astellas Pharma, Inc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Astellas Pharma, Inc. Recent Developments
Table 128. Pfizer, Inc. Corporation Information
Table 129. Pfizer, Inc. Description and Major Businesses
Table 130. Pfizer, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 131. Pfizer, Inc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Pfizer, Inc. Recent Developments
Table 133. AbbVie, Inc. Corporation Information
Table 134. AbbVie, Inc. Description and Major Businesses
Table 135. AbbVie, Inc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 136. AbbVie, Inc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. AbbVie, Inc. Recent Developments
Table 138. Allergan plc. Corporation Information
Table 139. Allergan plc. Description and Major Businesses
Table 140. Allergan plc. Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 141. Allergan plc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Allergan plc. Recent Developments
Table 143. Bristol-Myers Squibb Company Corporation Information
Table 144. Bristol-Myers Squibb Company Description and Major Businesses
Table 145. Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 146. Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Bristol-Myers Squibb Company Recent Developments
Table 148. Sanofi Corporation Information
Table 149. Sanofi Description and Major Businesses
Table 150. Sanofi Organ Transplant Rejection Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 151. Sanofi Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Sanofi Recent Developments
Table 153. Key Raw Materials Lists
Table 154. Raw Materials Key Suppliers Lists
Table 155. Organ Transplant Rejection Medicine Distributors List
Table 156. Organ Transplant Rejection Medicine Customers List
Table 157. Organ Transplant Rejection Medicine Market Trends
Table 158. Organ Transplant Rejection Medicine Market Drivers
Table 159. Organ Transplant Rejection Medicine Market Challenges
Table 160. Organ Transplant Rejection Medicine Market Restraints
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Rejection Medicine Product Picture
Figure 3. Global Organ Transplant Rejection Medicine Market Share by Type in 2021 & 2028
Figure 3. Steroids Product Picture
Figure 4. Antibodies Product Picture
Figure 5. mTOR Inhibitors Product Picture
Figure 6. Antiproliferative Agents Product Picture
Figure 7. Calcineurin Inhibitors Product Picture
Figure 8. Global Organ Transplant Rejection Medicine Market Share by Application in 2021 & 2028
Figure 9. Kidney Transplant
Figure 10. Bone Marrow Transplant
Figure 11. Liver Transplant
Figure 12. Heart Transplant
Figure 13. Lung Transplant
Figure 14. Others
Figure 15. Organ Transplant Rejection Medicine Report Years Considered
Figure 16. Global Organ Transplant Rejection Medicine Sales 2017-2028 (K Units)
Figure 17. Global Organ Transplant Rejection Medicine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 18. Global Organ Transplant Rejection Medicine Revenue 2017-2028 (US$ Million)
Figure 19. Global Organ Transplant Rejection Medicine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 20. Global Organ Transplant Rejection Medicine Sales Market Share by Region (2017-2022)
Figure 21. Global Organ Transplant Rejection Medicine Sales Market Share by Region (2023-2028)
Figure 22. North America Organ Transplant Rejection Medicine Sales YoY (2017-2028) & (K Units)
Figure 23. North America Organ Transplant Rejection Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Europe Organ Transplant Rejection Medicine Sales YoY (2017-2028) & (K Units)
Figure 25. Europe Organ Transplant Rejection Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific Organ Transplant Rejection Medicine Sales YoY (2017-2028) & (K Units)
Figure 27. Asia-Pacific Organ Transplant Rejection Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 28. Latin America Organ Transplant Rejection Medicine Sales YoY (2017-2028) & (K Units)
Figure 29. Latin America Organ Transplant Rejection Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 30. Middle East & Africa Organ Transplant Rejection Medicine Sales YoY (2017-2028) & (K Units)
Figure 31. Middle East & Africa Organ Transplant Rejection Medicine Revenue YoY (2017-2028) & (US$ Million)
Figure 32. The Organ Transplant Rejection Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 33. The Top 5 and 10 Largest Manufacturers of Organ Transplant Rejection Medicine in the World: Market Share by Organ Transplant Rejection Medicine Revenue in 2021
Figure 34. Global Organ Transplant Rejection Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 35. Global Organ Transplant Rejection Medicine Sales Market Share by Type (2017-2028)
Figure 36. Global Organ Transplant Rejection Medicine Revenue Market Share by Type (2017-2028)
Figure 37. Global Organ Transplant Rejection Medicine Sales Market Share by Application (2017-2028)
Figure 38. Global Organ Transplant Rejection Medicine Revenue Market Share by Application (2017-2028)
Figure 39. North America Organ Transplant Rejection Medicine Sales Market Share by Type (2017-2028)
Figure 40. North America Organ Transplant Rejection Medicine Revenue Market Share by Type (2017-2028)
Figure 41. North America Organ Transplant Rejection Medicine Sales Market Share by Application (2017-2028)
Figure 42. North America Organ Transplant Rejection Medicine Revenue Market Share by Application (2017-2028)
Figure 43. North America Organ Transplant Rejection Medicine Sales Share by Country (2017-2028)
Figure 44. North America Organ Transplant Rejection Medicine Revenue Share by Country (2017-2028)
Figure 45. United States Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 46. Canada Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 47. Europe Organ Transplant Rejection Medicine Sales Market Share by Type (2017-2028)
Figure 48. Europe Organ Transplant Rejection Medicine Revenue Market Share by Type (2017-2028)
Figure 49. Europe Organ Transplant Rejection Medicine Sales Market Share by Application (2017-2028)
Figure 50. Europe Organ Transplant Rejection Medicine Revenue Market Share by Application (2017-2028)
Figure 51. Europe Organ Transplant Rejection Medicine Sales Share by Country (2017-2028)
Figure 52. Europe Organ Transplant Rejection Medicine Revenue Share by Country (2017-2028)
Figure 53. Germany Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 54. France Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 55. U.K. Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 56. Italy Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 57. Russia Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 58. Asia Pacific Organ Transplant Rejection Medicine Sales Market Share by Type (2017-2028)
Figure 59. Asia Pacific Organ Transplant Rejection Medicine Revenue Market Share by Type (2017-2028)
Figure 60. Asia Pacific Organ Transplant Rejection Medicine Sales Market Share by Application (2017-2028)
Figure 61. Asia Pacific Organ Transplant Rejection Medicine Revenue Market Share by Application (2017-2028)
Figure 62. Asia Pacific Organ Transplant Rejection Medicine Sales Share by Region (2017-2028)
Figure 63. Asia Pacific Organ Transplant Rejection Medicine Revenue Share by Region (2017-2028)
Figure 64. China Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 65. Japan Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 66. South Korea Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 67. India Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 68. Australia Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 69. China Taiwan Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 70. Indonesia Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 71. Thailand Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 72. Malaysia Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Organ Transplant Rejection Medicine Sales Market Share by Type (2017-2028)
Figure 74. Latin America Organ Transplant Rejection Medicine Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Organ Transplant Rejection Medicine Sales Market Share by Application (2017-2028)
Figure 76. Latin America Organ Transplant Rejection Medicine Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Organ Transplant Rejection Medicine Sales Share by Country (2017-2028)
Figure 78. Latin America Organ Transplant Rejection Medicine Revenue Share by Country (2017-2028)
Figure 79. Mexico Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Organ Transplant Rejection Medicine Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Organ Transplant Rejection Medicine Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Organ Transplant Rejection Medicine Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Organ Transplant Rejection Medicine Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Organ Transplant Rejection Medicine Revenue Share by Country (2017-2028)
Figure 88. Turkey Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 90. UAE Organ Transplant Rejection Medicine Revenue (2017-2028) & (US$ Million)
Figure 91. Organ Transplant Rejection Medicine Value Chain
Figure 92. Organ Transplant Rejection Medicine Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

以下、関連資料のご紹介

臓器移植免疫抑制剤のグローバル市場 2021年：企業別、地域別、種類・用途別

Global Organ Transplant Immunosuppressant Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-203B16274 2021年12月 100Pages
臓器移植免疫抑制剤市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。...

抗TIGIT抗体のグローバル市場インサイト・予測（～2028年）

Global Anti-TIGIT Antibody Market Insights and Forecast to 2028
QY2203B09199 2022年3月 107Pages
新型コロナウイルス感染症のパンデミックにより、世界の抗TIGIT抗体の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗TIGIT抗体の世...

4-ヒドロキシ-3-メトキシベンゾニトリルのグローバル市場インサイト・予測（～2028年）

Global 4-Hydroxy-3-Methoxybenzonitrile Market Insights, Forecast to 2028
QY2203B00296 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の4-ヒドロキシ-3-メトキシベンゾニトリルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、202...

デオキシコール酸ナトリウムのグローバル市場インサイト・予測（～2028年）

Global Sodium Deoxycholate Market Insights, Forecast to 2028
QY2203B04182 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のデオキシコール酸ナトリウムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にデオキシコ...

スマトリプタンオートインジェクターのグローバル市場インサイト・予測（～2028年）

Global Sumatriptan Autoinjector Market Insights and Forecast to 2028
QY2203B03663 2022年3月 70Pages
新型コロナウイルス感染症のパンデミックにより、世界のスマトリプタンオートインジェクターの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にス...

N,N,N-トリメチルボラジンのグローバル市場インサイト・予測（～2028年）

Global N,N,N-Trimethylborazine Market Insights and Forecast to 2028
QY2203B00860 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のN,N,N-トリメチルボラジンの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にN,N...

ダイセパレーターのグローバル市場インサイト・予測（～2028年）

Global Die Separator Market Insights and Forecast to 2028
QY2203B03916 2022年3月 75Pages
新型コロナウイルス感染症のパンデミックにより、世界のダイセパレーターの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にダイセパレーターの世...

セラミック電池膜のグローバル市場インサイト・予測（～2028年）

Global Ceramic Battery Membrane Market Insights and Forecast to 2028
QY2203B03778 2022年3月 93Pages
新型コロナウイルス感染症のパンデミックにより、世界のセラミック電池膜の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にセラミック電池膜の世...

4,4′-ビフェニルジカルボキシアルデヒドのグローバル市場インサイト・予測（～2028年）

Global 4,4'-Biphenyldicarboxaldehyde Market Insights, Forecast to 2028
QY2203B00271 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の4,4'-ビフェニルジカルボキシアルデヒドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、202...

チタン自転車のグローバル市場インサイト・予測（～2028年）

Global Titanium Bicycles Market Insights and Forecast to 2028
QY2203B04075 2022年3月 87Pages
新型コロナウイルス感染症のパンデミックにより、世界のチタン自転車の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にチタン自転車の世界市場の...

臓器移植免疫抑制剤のグローバル市場 2021年：企業別、地域別、種類・用途別 The Organ Transplant Immunosuppressant market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
ブルトン型チロシンキナーゼ（BTK）阻害剤のグローバル市場インサイト・予測（～2028年） BTK inhibitors are able to interfere with cell signaling cascades and prevent key phosphorylations in B cells, therefore preventing or reducing inflammation. Market Analysis and Insights: Global Bruton Tyrosine Kinase (BTK) Inhibitors Market Due to the COVID-19 pandemic, the global Bruton Tyrosine K…
移植モニタリングキットのグローバル市場 2021年：企業別、地域別、種類・用途別 The Transplant Monitoring Kits market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
抗TIGIT抗体のグローバル市場インサイト・予測（～2028年） A human monoclonal antibody targeting the co-inhibitory molecule and immune checkpoint inhibitor T-cell immunoreceptor with immunoglobulin (Ig) and immunoreceptor tyrosine-based inhibitory motif (ITIM) domains (TIGIT), with potential immune checkpoint inhibitory activity. Market Analysis and Insight…
臓器ケア製品のグローバル市場 2021年：企業別、地域別、種類・用途別 The Organ Care Products market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…